<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-20225" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Phyllodes Tumor of the Breast</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Limaiem</surname>
            <given-names>Faten</given-names>
          </name>
          <aff>University of Tunis El Manar, Tunis Faculty of Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kashyap</surname>
            <given-names>Sarang</given-names>
          </name>
          <aff>Beckley Appalachian Regional Healthcare Hospital</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Faten Limaiem declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sarang Kashyap declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>1</day>
          <month>1</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-20225.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Phyllodes tumor of the breast is a relatively rare fibroepithelial neoplasm that presents a morphologic continuum from benign to malignant. Most phyllodes tumors behave benignly, with local recurrences occurring in a small proportion of cases. Very rarely, the tumor may metastasize. This activity describes the evaluation and treatment of phyllodes tumors and highlights the interprofessional team's role in managing patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of phyllodes breast tumors.</p></list-item><list-item><p>Assess&#x000a0;the evaluation of phyllodes breast tumors.</p></list-item><list-item><p>Evaluate&#x000a0;the treatment and management options available for phyllodes tumors of the breast.</p></list-item><list-item><p>Communicate&#x000a0;interprofessional team strategies for improving care coordination to advance the management of phyllodes breast tumors and improve outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=20225&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=20225">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-20225.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Phyllodes tumor of the breast is an infrequently encountered fibroepithelial neoplasm, which accounts for 0.3% to 1% of all tumors.<xref ref-type="bibr" rid="article-20225.r1">[1]</xref> Phyllodes tumor presents a morphologic continuum from benign to malignant (see <bold>Image.</bold> Phyllodes Tumor of the Breast, Benign. H/E 4&#x000d7;). Based on histologic features, including nuclear atypia, stromal cellularity, mitotic activity, tumor margin appearance, and stromal overgrowth, the World Health Organization classifies Phyllodes tumors as benign, borderline, and malignant.<xref ref-type="bibr" rid="article-20225.r1">[1]</xref> Phyllodes tumors have an inherent recurrence or metastatic potential, which varies based on histologic grade. Their diagnosis is mainly established based on histopathological examination. However, the differential diagnosis between benign phyllodes tumors and fibroadenoma remains challenging, especially on core biopsy specimens.</p>
      </sec>
      <sec id="article-20225.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Genetic risk factors of phyllodes tumors are largely unknown, but the literature describes phyllodes tumors in Li-Fraumeni syndrome patients and a mother and daughter pair.<xref ref-type="bibr" rid="article-20225.r2">[2]</xref> Rare cases of phyllodes tumors in men are often associated with gynecomastia, suggesting a role for hormonal imbalance.<xref ref-type="bibr" rid="article-20225.r3">[3]</xref>&#x000a0;Researchers have postulated that stromal induction of phyllodes tumors can occur due to growth factors produced by the breast epithelium. Trauma, pregnancy, increased estrogen activity, and lactation are occasionally implicated as factors stimulating tumor growth. The nature of these factors is not well understood, but endothelin-1, a stimulator of breast fibroblast growth, might be a contributory factor.<xref ref-type="bibr" rid="article-20225.r4">[4]</xref></p>
      </sec>
      <sec id="article-20225.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Phyllodes tumors occur predominantly in middle-aged women (average age at presentation, 40 to 50 years), about 15 to 20 years later than fibroadenomas.<xref ref-type="bibr" rid="article-20225.r5">[5]</xref>&#x000a0;Phyllodes tumor occurs mainly in women, although there are reports of some cases in men.<xref ref-type="bibr" rid="article-20225.r6">[6]</xref>&#x000a0;Data analysis from the Surveillance, Epidemiology, and End Results Program data registry from 2000 to 2004 reported that 500 women are diagnosed with malignant phyllodes tumors in the US annually.<xref ref-type="bibr" rid="article-20225.r7">[7]</xref></p>
      </sec>
      <sec id="article-20225.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Unlike breast carcinoma, phyllodes tumors start outside the lobules and ducts in the breast&#x02019;s connective tissue, called the stroma, including the ligaments and fatty tissue surrounding the lobules, ducts, lymph, and blood vessels in the breast. In addition to epithelial cells from the ducts and lobules, phyllodes tumors can also contain stromal cells.<xref ref-type="bibr" rid="article-20225.r8">[8]</xref> They most likely develop de novo, although there have been reports of progression of fibroadenoma to phyllodes tumor.<xref ref-type="bibr" rid="article-20225.r9">[9]</xref></p>
        <p>
<bold>Molecular Features</bold>
</p>
        <p>Recent studies have focused on defining a molecular classification of phyllodes tumors. Comparative genomic hybridization studies showed recurrent chromosome imbalances, including +1q, &#x02212;6q, &#x02212;13q, &#x02212;9p, &#x02212;10p, and +5p. Although currently no chromosomal aberrations were found to be specific to phyllodes tumors, some authors reported that low-grade and high-grade (borderline/malignant) phyllodes tumors segregate in&#x000a0;2 genetic groups based on genomic alterations, with high-grade phyllodes tumors consistently showing 1q gain and 13q loss and low-grade phyllodes tumors showing few or no alterations.<xref ref-type="bibr" rid="article-20225.r10">[10]</xref> Preliminary data from array comparative genomic hybridization demonstrate interstitial deletion 9p21 involving the CDKN2A locus and 9p deletion in malignant and some borderline phyllodes tumors.<xref ref-type="bibr" rid="article-20225.r11">[11]</xref></p>
      </sec>
      <sec id="article-20225.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>
<bold>Macroscopic Examination</bold>
</p>
        <p>Phyllodes tumors form well-circumscribed, firm, protruding masses. When cut, the surface is tan or pink to grey and may present as fleshy and mucoid. The characteristic whorled pattern with curved clefts resembling leaf buds is most evident in large lesions, but smaller lesions may have a homogeneous appearance. Hemorrhage or necrosis may be present in large lesions.<xref ref-type="bibr" rid="article-20225.r1">[1]</xref></p>
        <p>
<bold>Microscopic Examination</bold>
</p>
        <p>Phyllodes tumors exhibit an enhanced intra-canalicular growth pattern with leaf-like projections into variably dilated elongated lumina. The epithelial component consists of luminal epithelial and myoepithelial cells stretched into arc-like clefts surmounting stromal fronds.<xref ref-type="bibr" rid="article-20225.r1">[1]</xref></p>
        <p>
<bold>Grading</bold>
</p>
        <p>There have been proposals for several grading systems, but using the 3-tiered system, including benign, borderline, and malignant phyllodes tumors, is preferred because this approach leads to greater certainty at the ends of the spectrum of these fibroepithelial lesions.<xref ref-type="bibr" rid="article-20225.r1">[1]</xref></p>
        <p>
<bold>Benign Phyllodes Tumors</bold>
</p>
        <p>This variety comprises 60% to 75% of all phyllodes tumors (see&#x000a0;<bold>Image.</bold> Benign Phyllodes Tumor of the Breast. H/E 4&#x000d7;). In benign phyllodes tumors, the stroma is usually more cellular than in fibroadenomas. The spindle-cell stromal nuclei are uniform, and mitoses are rare, generally less than 5 per 10 high-power fields. Areas of sparse stromal cellularity, hyalinization, or myxoid changes are not uncommon, reflecting stromal heterogeneity. The margins are usually well-delimited and pushing.<xref ref-type="bibr" rid="article-20225.r1">[1]</xref></p>
        <p>
<bold>Borderline Phyllodes Tumors</bold>
</p>
        <p>These tumors are diagnosed when the mass does not possess all the adverse histological characteristics of malignant phyllodes tumors.&#x000a0;Borderline phyllodes tumors may have frequent mitoses (5 to 9 per 10 HPF), moderate stromal cellularity, a circumscribed or focally invasive border,&#x000a0; and stromal atypia. Stromal overgrowth is often absent.</p>
        <p>
<bold>Malignant Phyllodes Tumors</bold>
</p>
        <p>Malignant phyllode tumors show a combination of marked nuclear pleomorphism of stromal cells, stromal overgrowth defined as the absence of epithelial elements in&#x000a0;1 low-power microscopic field containing only stroma, increased mitoses (greater than or equal to 10 per 10 HPF), increased stromal cellularity, which is usually diffuse, and infiltrative borders.<xref ref-type="bibr" rid="article-20225.r1">[1]</xref></p>
        <p>
<bold>Immunohistochemistry</bold>
</p>
        <p>Multiple immunohistochemistry markers have undergone a study to improve the classification of PT and predict their outcomes. Studies demonstrate that p53, Ki67, CD117, EGFR, p16, and VEGF (the lowest in benign phyllodes tumors and the highest in malignant phyllodes tumors) are associated with histologic grades of phyllodes tumors. Still, none has been proven to be clinically useful.<xref ref-type="bibr" rid="article-20225.r12">[12]</xref><xref ref-type="bibr" rid="article-20225.r13">[13]</xref><xref ref-type="bibr" rid="article-20225.r14">[14]</xref><xref ref-type="bibr" rid="article-20225.r15">[15]</xref>&#x000a0;Among these markers, p53 expression and Ki67 index were reported in some studies to be significantly associated with disease-free and overall survival. Still, other studies found no association with recurrence or clinical behavior.<xref ref-type="bibr" rid="article-20225.r16">[16]</xref><xref ref-type="bibr" rid="article-20225.r17">[17]</xref>&#x000a0;PAX3 and SIX1 expression by immunohistochemistry and gene expression analysis have recently been identified in borderline and malignant phyllodes tumors and correlate with a poor clinical outcome.<xref ref-type="bibr" rid="article-20225.r18">[18]</xref></p>
      </sec>
      <sec id="article-20225.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Clinically, phyllodes tumors tend to present as unilateral firm, enlarging painless breast masses that stretch the overlying skin with striking distension of superficial veins. The size may range from 1 to 45 cm and occupy the entire breast. Bloody nipple discharge caused by spontaneous infarction of the tumor has been described. Ulceration and nipple retraction are uncommon. Although axillary lymphadenopathy is common, nodal metastases are the exception.<xref ref-type="bibr" rid="article-20225.r19">[19]</xref></p>
      </sec>
      <sec id="article-20225.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The imaging findings on mammography are typically round-lobulated dense masses with partially indistinct or circumscribed margins. Calcifications within the mass are rare, but they can be large.<xref ref-type="bibr" rid="article-20225.r20">[20]</xref>&#x000a0;On ultrasound, phyllodes tumor presents as a hypoechoic, partially indistinct, or partially circumscribed mass with frequent posterior enhancement. A cystic component is more typical in malignant phyllodes tumors. Frequently, phyllodes tumors show increased vascularity on color or power Doppler.<xref ref-type="bibr" rid="article-20225.r21">[21]</xref>&#x000a0;MRI evaluation may be beneficial for chest wall invasion in malignant phyllodes tumor. The characteristics present on MRI are typically heterogeneously low signal on T1-weighted images, although areas of T1-hyperintense hemorrhage may be visible. T2-weighted images usually show a lobulated mass with hyperintense fluid in slit-like spaces and sometimes hyperintensity in the surrounding tissues.<xref ref-type="bibr" rid="article-20225.r22">[22]</xref></p>
      </sec>
      <sec id="article-20225.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Complete wide local excision with greater than 1 cm margins is often curative and reduces the risk of local recurrence.<xref ref-type="bibr" rid="article-20225.r23">[23]</xref>&#x000a0; Large tumors require a mastectomy. Despite the higher incidence of local recurrence secondary to breast-conserving surgery, studies have shown no differences between breast-conserving surgery versus mastectomy&#x000a0;regarding&#x000a0;metastasis-free survival or overall survival. Adjuvant therapy options mainly include radiation therapy, which has been found to reduce local recurrence. Research has not shown a clinical benefit of giving adjuvant chemotherapy.<xref ref-type="bibr" rid="article-20225.r24">[24]</xref></p>
      </sec>
      <sec id="article-20225.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis for phyllodes tumor of the breast is as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Fibroadenoma:</bold> The principal differential diagnosis for benign phyllodes tumor is fibroadenoma, which has a pronounced intracanalicular pattern.<xref ref-type="bibr" rid="article-20225.r25">[25]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Sarcomas</bold>: malignant phyllodes tumor may be confused with pure breast sarcomas.<xref ref-type="bibr" rid="article-20225.r26">[26]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Periductal stromal tumor</bold>: the periductal stromal tumor is an entity that histologically overlaps with malignant phyllodes tumor, the main difference being the absence of leaf-like processes. It is non-circumscribed, consisting of spindle-cell proliferation localized around open tubules.<xref ref-type="bibr" rid="article-20225.r27">[27]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Metaplastic carcinoma</bold>: carcinoma is also in the differential diagnosis of malignant phyllodes tumor, but the immunohistochemical demonstration of epithelial differentiation helps resolve the problem.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-20225.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis of phyllodes tumor is good, with an 87% 10-year survival. The recurrence risk varies with tumor size and surgical approach. Most phyllodes tumors behave benignly, with local recurrences occurring in a small proportion of cases. Very rarely, the tumor may metastasize, most commonly in malignant-grade tumors.&#x000a0;Malignant phyllodes tumors carry a poor prognosis.</p>
      </sec>
      <sec id="article-20225.s12" sec-type="Complications">
        <title>Complications</title>
        <p>
<bold>Local Recurrence</bold>
</p>
        <p>Local recurrences can occur in all phyllodes tumors at an overall rate of 21%, with ranges of 10% to 17%, 14% to 25%, and 23% to 30% for benign, borderline malignant, and phyllodes tumors, respectively. Local recurrences generally develop within 2 to 3 years.<xref ref-type="bibr" rid="article-20225.r28">[28]</xref></p>
        <p>
<bold>Distant Metastases</bold>
</p>
        <p>Distant metastases are almost exclusively a feature of malignant phyllodes tumors. The lungs (66%), the bones (28%), and the brain (9%) are the most common sites of spread.<xref ref-type="bibr" rid="article-20225.r28">[28]</xref> Rarely, metastases can involve the liver and heart.</p>
      </sec>
      <sec id="article-20225.s13" sec-type="Consultations">
        <title>Consultations</title>
        <p>Consultations that are typically requested for patients with phyllodes tumor of the breast include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Surgical oncologist</p>
          </list-item>
          <list-item>
            <p>Oncologist</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-20225.s14" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients might be instructed to self-examine their breasts regularly and consult their doctors if any abnormality is detected.</p>
      </sec>
      <sec id="article-20225.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Accurate preoperative pathological diagnosis of phyllodes tumors enables adequate surgical planning and avoidance of reoperation. The distinction between&#x000a0;phyllodes tumor and fibroadenoma is important but can be difficult on core biopsy. Management of phyllodes tumors needs an interprofessional team consisting of a surgical oncologist, an oncologist, a pathologist, a radiologist, and oncology specialty-trained nurses, all working together as an interprofessional team to deliver the best clinical results. The primary care provider must refer patients with suspected breast masses to an oncologist for further workup. Treatment can be either wide local excision or mastectomy to achieve histologically clear margins.&#x000a0;After treating the phyllodes tumor, long-term&#x000a0;follow-up by the primary care providers is necessary to detect local and distant relapse.&#x000a0;</p>
      </sec>
      <sec id="article-20225.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=20225&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=20225">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/womens-health/phyllodes-tumor-of-the-breast/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=20225">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/20225/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=20225">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-20225.s17">
        <fig id="article-20225.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Phyllodes Tumor of the Breast, Benign. H/E 4&#x000d7; Contributed by F Farci, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="filloide01" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-20225.s18">
        <fig id="article-20225.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Benign Phyllodes Tumor of the Breast. H/E 4&#x000d7; Contributed by F Farci, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="filloide02" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-20225.s19">
        <title>References</title>
        <ref id="article-20225.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kleer</surname>
                <given-names>CG</given-names>
              </name>
            </person-group>
            <article-title>Phyllodes Tumor of the Breast: Histopathologic Features, Differential Diagnosis, and Molecular/Genetic Updates.</article-title>
            <source>Arch Pathol Lab Med</source>
            <year>2016</year>
            <month>Jul</month>
            <volume>140</volume>
            <issue>7</issue>
            <fpage>665</fpage>
            <page-range>665-71</page-range>
            <pub-id pub-id-type="pmid">27362571</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20225.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Foucar</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Hardy</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Siziopikou</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Parini</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Hansen</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Jeruss</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>A mother and daughter with phyllodes tumors of the breast.</article-title>
            <source>Clin Breast Cancer</source>
            <year>2012</year>
            <month>Oct</month>
            <volume>12</volume>
            <issue>5</issue>
            <fpage>373</fpage>
            <page-range>373-7</page-range>
            <pub-id pub-id-type="pmid">22981939</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20225.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nielsen</surname>
                <given-names>VT</given-names>
              </name>
              <name>
                <surname>Andreasen</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Phyllodes tumour of the male breast.</article-title>
            <source>Histopathology</source>
            <year>1987</year>
            <month>Jul</month>
            <volume>11</volume>
            <issue>7</issue>
            <fpage>761</fpage>
            <page-range>761-2</page-range>
            <pub-id pub-id-type="pmid">3040567</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20225.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mishra</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Tiwary</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Mishra</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Khanna</surname>
                <given-names>AK</given-names>
              </name>
            </person-group>
            <article-title>Phyllodes tumor of breast: a review article.</article-title>
            <source>ISRN Surg</source>
            <year>2013</year>
            <volume>2013</volume>
            <fpage>361469</fpage>
            <pub-id pub-id-type="pmid">23577269</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20225.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jing</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Wei</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>Phyllodes tumor of the breast with nipple discharge: A case report.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>97</volume>
            <issue>52</issue>
            <fpage>e13767</fpage>
            <pub-id pub-id-type="pmid">30593154</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20225.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ansah-Boateng</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Tavassoli</surname>
                <given-names>FA</given-names>
              </name>
            </person-group>
            <article-title>Fibroadenoma and cystosarcoma phyllodes of the male breast.</article-title>
            <source>Mod Pathol</source>
            <year>1992</year>
            <month>Mar</month>
            <volume>5</volume>
            <issue>2</issue>
            <fpage>114</fpage>
            <page-range>114-6</page-range>
            <pub-id pub-id-type="pmid">1315437</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20225.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Adesoye</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Neuman</surname>
                <given-names>HB</given-names>
              </name>
              <name>
                <surname>Wilke</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Schumacher</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Steiman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Greenberg</surname>
                <given-names>CC</given-names>
              </name>
            </person-group>
            <article-title>Current Trends in the Management of Phyllodes Tumors of the Breast.</article-title>
            <source>Ann Surg Oncol</source>
            <year>2016</year>
            <month>Oct</month>
            <volume>23</volume>
            <issue>10</issue>
            <fpage>3199</fpage>
            <page-range>3199-205</page-range>
            <pub-id pub-id-type="pmid">27334214</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20225.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mitus</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Blecharz</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Jakubowicz</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Reinfuss</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Walasek</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Wysocki</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Phyllodes tumors of the breast. The treatment results for 340 patients from a single cancer centre.</article-title>
            <source>Breast</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>43</volume>
            <fpage>85</fpage>
            <page-range>85-90</page-range>
            <pub-id pub-id-type="pmid">30521986</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20225.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Faridi</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Siddiqui</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ahmad</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Aslam</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Progression of Fibroadenoma to Malignant Phyllodes Tumour in a 14-Year Female.</article-title>
            <source>J Coll Physicians Surg Pak</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>28</volume>
            <issue>1</issue>
            <fpage>69</fpage>
            <page-range>69-71</page-range>
            <pub-id pub-id-type="pmid">29290198</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20225.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>La&#x000e9;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vincent-Salomon</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Savignoni</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Huon</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Fr&#x000e9;neaux</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sigal-Zafrani</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Aurias</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sastre-Garau</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Couturier</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Phyllodes tumors of the breast segregate in two groups according to genetic criteria.</article-title>
            <source>Mod Pathol</source>
            <year>2007</year>
            <month>Apr</month>
            <volume>20</volume>
            <issue>4</issue>
            <fpage>435</fpage>
            <page-range>435-44</page-range>
            <pub-id pub-id-type="pmid">17334353</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20225.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jones</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Mitter</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Springall</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Graham</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Winter</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gillett</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hanby</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Tomlinson</surname>
                <given-names>IP</given-names>
              </name>
              <name>
                <surname>Sawyer</surname>
                <given-names>EJ</given-names>
              </name>
              <collab>Phyllodes Tumour Consortium</collab>
            </person-group>
            <article-title>A comprehensive genetic profile of phyllodes tumours of the breast detects important mutations, intra-tumoral genetic heterogeneity and new genetic changes on recurrence.</article-title>
            <source>J Pathol</source>
            <year>2008</year>
            <month>Apr</month>
            <volume>214</volume>
            <issue>5</issue>
            <fpage>533</fpage>
            <page-range>533-44</page-range>
            <pub-id pub-id-type="pmid">18288784</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20225.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Noronha</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Raza</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hutchins</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Chase</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Garberoglio</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Chu</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Weiss</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>CD34, CD117, and Ki-67 expression in phyllodes tumor of the breast: an immunohistochemical study of 33 cases.</article-title>
            <source>Int J Surg Pathol</source>
            <year>2011</year>
            <month>Apr</month>
            <volume>19</volume>
            <issue>2</issue>
            <fpage>152</fpage>
            <page-range>152-8</page-range>
            <pub-id pub-id-type="pmid">21087983</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20225.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tan</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>Jayabaskar</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Yip</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Hilmy</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Selvarajan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bay</surname>
                <given-names>BH</given-names>
              </name>
            </person-group>
            <article-title>p53 and c-kit (CD117) protein expression as prognostic indicators in breast phyllodes tumors: a tissue microarray study.</article-title>
            <source>Mod Pathol</source>
            <year>2005</year>
            <month>Dec</month>
            <volume>18</volume>
            <issue>12</issue>
            <fpage>1527</fpage>
            <page-range>1527-34</page-range>
            <pub-id pub-id-type="pmid">16258510</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20225.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tse</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Lui</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Vong</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Lau</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Putti</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Karim</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Scolyer</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Ng</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Tse</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>PH</given-names>
              </name>
            </person-group>
            <article-title>Increased epidermal growth factor receptor (EGFR) expression in malignant mammary phyllodes tumors.</article-title>
            <source>Breast Cancer Res Treat</source>
            <year>2009</year>
            <month>Apr</month>
            <volume>114</volume>
            <issue>3</issue>
            <fpage>441</fpage>
            <page-range>441-8</page-range>
            <pub-id pub-id-type="pmid">18443904</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20225.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Karim</surname>
                <given-names>RZ</given-names>
              </name>
              <name>
                <surname>Gerega</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>YH</given-names>
              </name>
              <name>
                <surname>Spillane</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Carmalt</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Scolyer</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>CS</given-names>
              </name>
            </person-group>
            <article-title>p16 and pRb immunohistochemical expression increases with increasing tumour grade in mammary phyllodes tumours.</article-title>
            <source>Histopathology</source>
            <year>2010</year>
            <month>Jun</month>
            <volume>56</volume>
            <issue>7</issue>
            <fpage>868</fpage>
            <page-range>868-75</page-range>
            <pub-id pub-id-type="pmid">20497245</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20225.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yonemori</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hasegawa</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Shimizu</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Shibata</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Matsumoto</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kouno</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ando</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Katsumata</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Fujiwara</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Correlation of p53 and MIB-1 expression with both the systemic recurrence and survival in cases of phyllodes tumors of the breast.</article-title>
            <source>Pathol Res Pract</source>
            <year>2006</year>
            <volume>202</volume>
            <issue>10</issue>
            <fpage>705</fpage>
            <page-range>705-12</page-range>
            <pub-id pub-id-type="pmid">16889904</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20225.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Niezabitowski</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lackowska</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Rys</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kruczak</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kowalska</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Mitus</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Reinfuss</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Markiewicz</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Prognostic evaluation of proliferative activity and DNA content in the phyllodes tumor of the breast: immunohistochemical and flow cytometric study of 118 cases.</article-title>
            <source>Breast Cancer Res Treat</source>
            <year>2001</year>
            <month>Jan</month>
            <volume>65</volume>
            <issue>1</issue>
            <fpage>77</fpage>
            <page-range>77-85</page-range>
            <pub-id pub-id-type="pmid">11245343</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20225.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tan</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Thike</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Bay</surname>
                <given-names>BH</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>PH</given-names>
              </name>
            </person-group>
            <article-title>Immunohistochemical expression of homeoproteins Six1 and Pax3 in breast phyllodes tumours correlates with histological grade and clinical outcome.</article-title>
            <source>Histopathology</source>
            <year>2014</year>
            <month>May</month>
            <volume>64</volume>
            <issue>6</issue>
            <fpage>807</fpage>
            <page-range>807-17</page-range>
            <pub-id pub-id-type="pmid">24438019</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20225.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gullett</surname>
                <given-names>NP</given-names>
              </name>
              <name>
                <surname>Rizzo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Johnstone</surname>
                <given-names>PA</given-names>
              </name>
            </person-group>
            <article-title>National surgical patterns of care for primary surgery and axillary staging of phyllodes tumors.</article-title>
            <source>Breast J</source>
            <year>2009</year>
            <season>Jan-Feb</season>
            <volume>15</volume>
            <issue>1</issue>
            <fpage>41</fpage>
            <page-range>41-4</page-range>
            <pub-id pub-id-type="pmid">19141133</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20225.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tan</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Peng</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Mao</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Shen</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>Imaging findings in phyllodes tumors of the breast.</article-title>
            <source>Eur J Radiol</source>
            <year>2012</year>
            <month>Jan</month>
            <volume>81</volume>
            <issue>1</issue>
            <fpage>e62</fpage>
            <page-range>e62-9</page-range>
            <pub-id pub-id-type="pmid">21353414</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20225.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liberman</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bonaccio</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hamele-Bena</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Abramson</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Dershaw</surname>
                <given-names>DD</given-names>
              </name>
            </person-group>
            <article-title>Benign and malignant phyllodes tumors: mammographic and sonographic findings.</article-title>
            <source>Radiology</source>
            <year>1996</year>
            <month>Jan</month>
            <volume>198</volume>
            <issue>1</issue>
            <fpage>121</fpage>
            <page-range>121-4</page-range>
            <pub-id pub-id-type="pmid">8539362</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20225.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yoo</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Woo</surname>
                <given-names>OH</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>YK</given-names>
              </name>
              <name>
                <surname>Cho</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Yong</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Seo</surname>
                <given-names>BK</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>EY</given-names>
              </name>
            </person-group>
            <article-title>Can MR Imaging contribute in characterizing well-circumscribed breast carcinomas?</article-title>
            <source>Radiographics</source>
            <year>2010</year>
            <month>Oct</month>
            <volume>30</volume>
            <issue>6</issue>
            <fpage>1689</fpage>
            <page-range>1689-702</page-range>
            <pub-id pub-id-type="pmid">21071383</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20225.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pezner</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Schultheiss</surname>
                <given-names>TE</given-names>
              </name>
              <name>
                <surname>Paz</surname>
                <given-names>IB</given-names>
              </name>
            </person-group>
            <article-title>Malignant phyllodes tumor of the breast: local control rates with surgery alone.</article-title>
            <source>Int J Radiat Oncol Biol Phys</source>
            <year>2008</year>
            <month>Jul</month>
            <day>01</day>
            <volume>71</volume>
            <issue>3</issue>
            <fpage>710</fpage>
            <page-range>710-3</page-range>
            <pub-id pub-id-type="pmid">18234448</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20225.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ruiz-Flores</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ebuoma</surname>
                <given-names>LO</given-names>
              </name>
              <name>
                <surname>Benveniste</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Nagi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>OrtizPerez</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Benveniste</surname>
                <given-names>AP</given-names>
              </name>
            </person-group>
            <article-title>Case Report: Metastatic Phyllodes Tumor.</article-title>
            <source>Semin Ultrasound CT MR</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>39</volume>
            <issue>1</issue>
            <fpage>122</fpage>
            <page-range>122-126</page-range>
            <pub-id pub-id-type="pmid">29317034</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20225.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yasir</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nassar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jimenez</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Jenkins</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Hartmann</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Degnim</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Frost</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Visscher</surname>
                <given-names>DW</given-names>
              </name>
            </person-group>
            <article-title>Cellular fibroepithelial lesions of the breast: A long term follow up study.</article-title>
            <source>Ann Diagn Pathol</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>35</volume>
            <fpage>85</fpage>
            <page-range>85-91</page-range>
            <pub-id pub-id-type="pmid">30029048</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20225.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goto</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Kashiwagi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Takada</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Asano</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Morisaki</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Noda</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Takashima</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Onoda</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Hirakawa</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ohira</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>[A Case of a Malignant Phyllodes Tumor That Was Difficult to Distinguish from Stromal Sarcoma].</article-title>
            <source>Gan To Kagaku Ryoho</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>45</volume>
            <issue>13</issue>
            <fpage>2429</fpage>
            <page-range>2429-2431</page-range>
            <pub-id pub-id-type="pmid">30692487</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20225.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Burga</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Tavassoli</surname>
                <given-names>FA</given-names>
              </name>
            </person-group>
            <article-title>Periductal stromal tumor: a rare lesion with low-grade sarcomatous behavior.</article-title>
            <source>Am J Surg Pathol</source>
            <year>2003</year>
            <month>Mar</month>
            <volume>27</volume>
            <issue>3</issue>
            <fpage>343</fpage>
            <page-range>343-8</page-range>
            <pub-id pub-id-type="pmid">12604890</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20225.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tan</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>Thike</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Thu</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Busmanis</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Chay</surname>
                <given-names>WY</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>MH</given-names>
              </name>
              <collab>Phyllodes Tumour Network Singapore</collab>
            </person-group>
            <article-title>Predicting clinical behaviour of breast phyllodes tumours: a nomogram based on histological criteria and surgical margins.</article-title>
            <source>J Clin Pathol</source>
            <year>2012</year>
            <month>Jan</month>
            <volume>65</volume>
            <issue>1</issue>
            <fpage>69</fpage>
            <page-range>69-76</page-range>
            <pub-id pub-id-type="pmid">22049216</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
